Chenab Limited (PSX:CHBL)

Blueprint Medicines Statistics

Total Valuation

Chenab has a market cap or net worth of PKR 2.42 billion. The enterprise value is 11.46 billion.

Market Cap	2.42B
Enterprise Value	11.46B

Important Dates

The next estimated earnings date is Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Chenab has 115.00 million shares outstanding. The number of shares has decreased by -0.09% in one year.

Current Share Class	115.00M
Shares Outstanding	115.00M
Shares Change (YoY)	-0.09%
Shares Change (QoQ)	-0.55%
Owned by Insiders (%)	52.30%
Owned by Institutions (%)	n/a
Float	54.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.86
PB Ratio	-5.95
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-24.20
EV / Sales	4.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-207.34

Financial Position

The company has a current ratio of 0.45

Current Ratio	0.45
Quick Ratio	0.18
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-155.68
Interest Coverage	-2.70

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-3.21%
Return on Invested Capital (ROIC)	-4.00%
Return on Capital Employed (ROCE)	-6.58%
Revenue Per Employee	2.54M
Profits Per Employee	-426,903
Employee Count	1,109
Asset Turnover	0.26
Inventory Turnover	8.41

Taxes

In the past 12 months, Chenab has paid 14.39 million in taxes.

Income Tax	14.39M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +648.24% in the last 52 weeks. The beta is 0.67, so Chenab's price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	+648.24%
50-Day Moving Average	10.80
200-Day Moving Average	8.33
Relative Strength Index (RSI)	76.49
Average Volume (20 Days)	4,861,093

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Chenab had revenue of PKR 2.81 billion and -473.44 million in losses. Loss per share was -4.12.

Revenue	2.81B
Gross Profit	-29.83M
Operating Income	-551.49M
Pretax Income	-459.04M
Net Income	-473.44M
EBITDA	-355.43M
EBIT	-551.49M
Loss Per Share	-4.12

Balance Sheet

The company has 61.73 million in cash and 8.60 billion in debt, giving a net cash position of -8.54 billion or -74.26 per share.

Cash & Cash Equivalents	61.73M
Total Debt	8.60B
Net Cash	-8.54B
Net Cash Per Share	-74.26
Equity (Book Value)	-406.09M
Book Value Per Share	-7.88
Working Capital	-1.09B

Cash Flow

In the last 12 months, operating cash flow was -18.74 million and capital expenditures -36.51 million, giving a free cash flow of -55.25 million.

Operating Cash Flow	-18.74M
Capital Expenditures	-36.51M
Free Cash Flow	-55.25M
FCF Per Share	-0.48

Margins

Gross margin is -1.06%, with operating and profit margins of -19.61% and -16.83%.

Gross Margin	-1.06%
Operating Margin	-19.61%
Pretax Margin	-16.32%
Profit Margin	-16.83%
EBITDA Margin	-12.64%
EBIT Margin	-19.61%
FCF Margin	n/a

Dividends & Yields

Chenab does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.09%
Shareholder Yield	n/a
Earnings Yield	-19.59%
FCF Yield	-2.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Chenab has an Altman Z-Score of -1.14 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.14
Piotroski F-Score	2